{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:08:45Z","timestamp":1789088925957,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA046049"],"award-info":[{"award-number":["R01-DA046049"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009410","name":"Southern California Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["GR1068872"],"award-info":[{"award-number":["GR1068872"]}],"id":[{"id":"10.13039\/100009410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.dadr.2026.100468","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:12:27Z","timestamp":1786637547000},"page":"100468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Variations in the viral hepatitis C prevalence and treatment status by material hardship and cumulative risk among people who inject drugs"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4330-180X","authenticated-orcid":false,"given":"Sid S.","family":"Ganesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca P.","family":"Smeltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert A.","family":"Orta Portillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Dominguez","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srehith","family":"Sannareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley T.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky N.","family":"Bluthenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2026.100468_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103247","article-title":"Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis","volume":"96","author":"Amoako","year":"2021","journal-title":"Int. J. Drug. Policy"},{"key":"10.1016\/j.dadr.2026.100468_bib2","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2468-2667(21)00013-X","article-title":"Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis","volume":"6","author":"Arum","year":"2021","journal-title":"Lancet Public. Health"},{"issue":"2","key":"10.1016\/j.dadr.2026.100468_bib3","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of hepatitis C virus infection among people who are actively injecting drugs: A systematic review and meta-analysis","volume":"57","author":"Aspinall","year":"2013","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.dadr.2026.100468_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12879-025-12396-y","article-title":"Global, regional, and National burden of hepatitis C from 1990 to 2021 and projections until 2030","volume":"26","author":"Bai","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.dadr.2026.100468_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12954-017-0192-8","article-title":"Perceived benefits of the hepatitis C peer educators: a qualitative investigation","volume":"14","author":"Batchelder","year":"2017","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.dadr.2026.100468_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jvh.13761","article-title":"Hepatitis C virus-specific immune responses following direct-acting antivirals administered during recent hepatitis C virus infection","volume":"30","author":"Casey","year":"2023","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.dadr.2026.100468_bib7","unstructured":"Centers for Disease Control and Prevention, 2025. Hepatitis C Prevention and Control [WWW Document]. Hepat. C. URL https:\/\/www.cdc.gov\/hepatitis-c\/prevention\/index.html (accessed 11.2.25)."},{"issue":"1","key":"10.1016\/j.dadr.2026.100468_bib8","article-title":"Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study","volume":"20","author":"Chayama","year":"2023","journal-title":"J. infect. dis."},{"issue":"1","key":"10.1016\/j.dadr.2026.100468_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-13227-4","article-title":"Health risk associated with residential relocation among people who inject drugs in Los Angeles and San Francisco, CA: a cross sectional study","volume":"22","author":"Chiang","year":"2022","journal-title":"BMC public health"},{"key":"10.1016\/j.dadr.2026.100468_bib10","series-title":"Projected U.S. national Hepatitis C treatment costs and estimated reduction to medical costs","author":"Cline","year":"2021"},{"key":"10.1016\/j.dadr.2026.100468_bib11","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob. Health"},{"issue":"5","key":"10.1016\/j.dadr.2026.100468_bib12","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","article-title":"Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: A systematic review","volume":"11","author":"Degenhardt","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.dadr.2026.100468_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2025.104712","article-title":"Monitoring hepatitis C elimination among people who inject drugs: A broader approach is required","volume":"137","author":"Dore","year":"2025","journal-title":"Int. J. Drug. Policy"},{"issue":"4","key":"10.1016\/j.dadr.2026.100468_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/107319119400100407","article-title":"Reliability of drug users\u2019 self-reported HIV risk behaviors and validity of self-reported recent drug use","volume":"1","author":"Dowling-Guyer","year":"1994","journal-title":"Assessment"},{"key":"10.1016\/j.dadr.2026.100468_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac225","article-title":"Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial","volume":"9","author":"Eckhardt","year":"2022","journal-title":"Open. Forum Infect. Dis."},{"key":"10.1016\/j.dadr.2026.100468_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamainternmed.2022.0170","article-title":"Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial","volume":"182","author":"Eckhardt","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.dadr.2026.100468_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102714","article-title":"Individual and network factors associated with HCV treatment uptake among people who inject drugs","volume":"78","author":"Falade-Nwulia","year":"2020","journal-title":"Int. J. Drug. Policy"},{"issue":"1","key":"10.1016\/j.dadr.2026.100468_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40615-023-01878-x","article-title":"HIV and Hepatitis C Among People Who Inject Drugs in Memphis, Tennessee: An Intersectional Risk Environment Analysis of the Social Determinants of Health","volume":"12","author":"Flath","year":"2025","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"10.1016\/j.dadr.2026.100468_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/10826084.2025.2519400","article-title":"It\u2019s not just one decision, it\u2019sa whole lifestyle change\u201d: Mixed methods analysis of factors associated with readiness to change substance use patterns among community recruited people who inject drugs","author":"Ford","year":"2025","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2026.100468_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12954-021-00519-y","article-title":"Therapy of chronic hepatitis C in people who inject drugs: Focus on adherence","volume":"18","author":"Frankova","year":"2021","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.dadr.2026.100468_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2025.104864","article-title":"Heroin injection to fentanyl smoking: Examining temporal trends in substance type and route of administration among people who inject drugs in Los Angeles, CA and Denver, CO, USA between 2021\u20132022","volume":"143","author":"Ganesh","year":"2025","journal-title":"Int. J. Drug. Policy"},{"issue":"2","key":"10.1016\/j.dadr.2026.100468_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2105\/AJPH.87.2.217","article-title":"Competing priorities as a barrier to medical care among homeless adults in Los Angeles","volume":"87","author":"Gelberg","year":"1997","journal-title":"Am. J. Public. Health"},{"key":"10.1016\/j.dadr.2026.100468_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104574","article-title":"Putting the capital in recovery capital: An exploration of universal basic income and the impacts for people who use drugs in Canada","volume":"133","author":"Gibson","year":"2024","journal-title":"Int. J. Drug. Policy"},{"key":"10.1016\/j.dadr.2026.100468_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12889-025-21626-6","article-title":"Material hardship, forced displacement, and negative health outcomes among unhoused people who use drugs in Los Angeles, California and Denver, Colorado: a latent class analysis","volume":"25","author":"Goldshear","year":"2025","journal-title":"BMC Public. Health"},{"key":"10.1016\/j.dadr.2026.100468_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2023.116408","article-title":"Notice of major cleaning\": A qualitative study of the negative impact of encampment sweeps on the ontological security of unhoused people who use drugs","volume":"339","author":"Goldshear","year":"2023","journal-title":"Soc Sci Med."},{"key":"10.1016\/j.dadr.2026.100468_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10826084.2021.1879149","article-title":"Novel Routes of Potential Hepatitis C Virus Transmission among People Who Inject Drugs: Secondary Blood Exposures Related to Injection Drug Use","volume":"56","author":"Goldshear","year":"2021","journal-title":"Subst. Use Misuse"},{"issue":"10","key":"10.1016\/j.dadr.2026.100468_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: The influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.dadr.2026.100468_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","article-title":"Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion","volume":"15","author":"Hagan","year":"2004","journal-title":"Epidemiology"},{"key":"10.1016\/j.dadr.2026.100468_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives","author":"Hu","year":"1999","journal-title":"Struct. Equ. Model. A Multidiscip. J."},{"key":"10.1016\/j.dadr.2026.100468_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241615","article-title":"Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system","volume":"15","author":"Javanbakht","year":"2020","journal-title":"PloS. One"},{"issue":"1","key":"10.1016\/j.dadr.2026.100468_bib31","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/S2468-2667(24)00275-5","article-title":"Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons","volume":"10","author":"Kronfli","year":"2025","journal-title":"The Lancet. Public health"},{"issue":"12","key":"10.1016\/j.dadr.2026.100468_bib32","first-page":"2244","article-title":"Staying hepatitis C negative: A systematic review and meta-analysis of cure and reinfection in people who inject drugs","volume":"39","author":"Latham","year":"2019","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"issue":"2","key":"10.1016\/j.dadr.2026.100468_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228767","article-title":"A financial incentive program to improve appointment attendance at a safety-net hospital-based primary care hepatitis C treatment program","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS. ONE"},{"key":"10.1016\/j.dadr.2026.100468_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207226","article-title":"Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?","volume":"13","author":"Madden","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.dadr.2026.100468_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107705","article-title":"Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists-The practitioner experience","volume":"206","author":"Marshall","year":"2020","journal-title":"Drug. Alcohol. Depend."},{"issue":"2","key":"10.1016\/j.dadr.2026.100468_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1377\/hlthaff.2023.01040","article-title":"Encampment Clearings And Transitional Housing: A Qualitative Analysis Of Resident Perspectives: Study analyzes responses from former homeless encampment residents and their experiences with transitional housing","volume":"43","author":"Mayer","year":"2024","journal-title":"Health Aff."},{"issue":"Suppl 3","key":"10.1016\/j.dadr.2026.100468_bib37","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1093\/infdis\/jiac292","article-title":"The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection","volume":"226","author":"Miller-Archie","year":"2022","journal-title":"J. infect. dis."},{"key":"10.1016\/j.dadr.2026.100468_bib38","first-page":"831","article-title":"Housing Stability and Hepatitis C Infection for Young Adults Who Inject Drugs: Examining the Relationship of Consistent and Intermittent Housing Status on HCV Infection Risk","volume":"97","author":"Morris","year":"2020","journal-title":"J. Urban. Health Bull. N. Y. Acad. Med."},{"issue":"3","key":"10.1016\/j.dadr.2026.100468_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amepre.2023.10.019","article-title":"State Supplemental Nutrition Assistance Program Policies and Substance Use Rates","volume":"66","author":"Naumann","year":"2024","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.dadr.2026.100468_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45424","article-title":"Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States","volume":"5","author":"Nguyen","year":"2022","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.dadr.2026.100468_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.spl.2026.110698","article-title":"Robust variance estimators for risk ratio estimators from logistic regression in cohort and case-cohort studies","volume":"234","author":"Noma","year":"2026","journal-title":"Stat. & Probab. Lett."},{"key":"10.1016\/j.dadr.2026.100468_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2019.02.009","article-title":"Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs: A pilot study","volume":"69","author":"Norton","year":"2019","journal-title":"Int. J. Drug. Policy"},{"key":"10.1016\/j.dadr.2026.100468_bib43","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajcnut.2023.12.019","article-title":"Food Insecurity, Neighborhood Food Environment, and Health Disparities: State of the Science, Research Gaps and Opportunities","volume":"119","author":"Odoms-Young","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.dadr.2026.100468_bib44","article-title":"Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States","volume":"32","author":"Park","year":"2023","journal-title":"Prev. Med. Rep."},{"issue":"1","key":"10.1016\/j.dadr.2026.100468_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12954-022-00594-9","article-title":"Meeting people where they are: Implementing hospital-based substance use harm reduction","volume":"19","author":"Perera","year":"2022","journal-title":"Harm Reduct. J."},{"issue":"39, 2010","key":"10.1016\/j.dadr.2026.100468_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.anthro.012809.105101","article-title":"Anthropological Perspectives on Structural Adjustment and Public Health","volume":"39","author":"Pfeiffer","year":"2010","journal-title":"Annu. Rev. Anthropol."},{"issue":"3","key":"10.1016\/j.dadr.2026.100468_bib47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addctn. (Abingdon Engl.)"},{"key":"10.1016\/j.dadr.2026.100468_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/01459740.2011.576725","article-title":"Structural Vulnerability and Health: Latino Migrant Laborers in the United States","volume":"30","author":"Quesada","year":"2011","journal-title":"Med. Anthropol."},{"key":"10.1016\/j.dadr.2026.100468_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14302\/issn.2574-4526.jddd-19-2770","article-title":"Successful Cascade of Care and Cure HCV in 5382 Drugs Users: How Increase HCV Treatment by Outreach Care, Since Screening to Treatment","volume":"1","author":"Remy","year":"2019","journal-title":"J. Dig. Disord. Diagn."},{"key":"10.1016\/j.dadr.2026.100468_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: An R Package for Structural Equation Modeling","volume":"48","author":"Rosseel","year":"2012","journal-title":"J. Stat. Softw."},{"issue":"2","key":"10.1016\/j.dadr.2026.100468_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2307\/1403146","article-title":"Model Robust Confidence Intervals Using Maximum Likelihood Estimators","volume":"54","author":"Royall","year":"1986","journal-title":"Int. Stat. Rev. \/ Rev. Int. De. Stat."},{"key":"10.1016\/j.dadr.2026.100468_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103588","article-title":"Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs: A systematic review and practical considerations from an expert panel consultation","volume":"102","author":"Schwarz","year":"2022","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.dadr.2026.100468_bib53","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.jceh.2023.07.242","article-title":"A community led integrated test and treat strategy for hepatitis C treatment and hepatitis B vaccination in people who inject drugs (PWID): a model for micro-elimination","volume":"13","author":"Singh","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.dadr.2026.100468_bib54","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.10.009","article-title":"Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection","volume":"183","author":"Spengler","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.dadr.2026.100468_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13722-021-00260-8","article-title":"Treat my whole person, not just my condition\u2019: qualitative explorations of hepatitis C care delivery preferences among people who inject drugs","volume":"16","author":"Tsui","year":"2021","journal-title":"Addict. Sci. & Clin. Pract."},{"key":"10.1016\/j.dadr.2026.100468_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104394","article-title":"Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study","volume":"127","author":"Valerio","year":"2024","journal-title":"Int. J. Drug. Policy"},{"issue":"13","key":"10.1016\/j.dadr.2026.100468_bib57","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.3390\/ijerph16132345","article-title":"Factors Correlating to the Development of Hepatitis C Virus Infection among Drug Users\u2014Findings from a Systematic Review and Meta-Analysis","volume":"16","author":"Zhou","year":"2019","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"5","key":"10.1016\/j.dadr.2026.100468_bib58","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/ije\/24.5.1064","article-title":"Estimation of prevalence rate ratios from cross-sectional data","volume":"24","author":"Zocchetti","year":"1995","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.dadr.2026.100468_bib59","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:20:56Z","timestamp":1789086056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724626000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"alternative-id":["S2772724626000612"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100468","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variations in the viral hepatitis C prevalence and treatment status by material hardship and cumulative risk among people who inject drugs","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100468"}}